-
Annexin V-APC/7-AAD Apoptosis Kit for NETs
2026-08-14
The Annexin V-APC/7-AAD Apoptosis Kit provides rapid apoptosis and necrosis detection for studying tumor-targeted PAD4 inhibition and neutrophil extracellular traps. This guide explains how to interpret phosphatidylserine exposure without confusing reduced NET formation with direct tumor-cell killing.
-
MTT Assay: Reliable Cell Viability Workflows
2026-08-14
This scenario-based guide explains how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide), SKU B7777, can improve interpretation and reproducibility in colorimetric cell viability, proliferation, and cytotoxicity assays. It covers assay principles, controls, reagent preparation, metabolic confounders, protocol parameters, and practical product-selection criteria.
-
Dorsomorphin (Compound C) in AMPK–Mitophagy Studies
2026-08-13
Dorsomorphin (Compound C) helps separate AMPK-dependent mitophagy from BMP/Smad effects in cell and animal workflows. This guide translates a 2025 skeletal-muscle study into practical assay design, handling, control selection, and troubleshooting strategies.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-13
This study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Through gain- and loss-of-function experiments, RNA decay analysis, RNA immunoprecipitation, and tumor–macrophage co-culture models, the authors connect RP3-340N1.2 to cancer-cell proliferation, migration, and tumor-associated macrophage behavior.
-
Dacomitinib: Designing ErbB and Ferroptosis Assays
2026-08-12
Dacomitinib (PF-00299804) enables rigorous studies of irreversible ErbB signaling blockade, apoptosis, and cell-cycle control. This article presents a decision-based assay framework for examining its established anticancer effects alongside, but not conflated with, emerging mitochondrial ferroptosis biology.
-
Flumequine for DNA Topoisomerase II Assays
2026-08-12
Flumequine provides a practical chemical probe for connecting DNA topoisomerase II activity with replication stress, viability, and cell-death phenotypes. This workflow emphasizes solvent control, time-resolved measurements, and orthogonal readouts so researchers can distinguish enzyme inhibition from delayed cytotoxicity.
-
S Tag Peptide: Workflow, QC, and Troubleshooting
2026-08-11
S Tag Peptide supports recombinant protein detection, antibody-based purification, and protein solubility improvement when encoded as an N- or C-terminal S-peptide fusion tag. It is appropriate for aqueous protein expression and purification workflows, but the free peptide is not a standalone ribonuclease reagent, is insoluble in ethanol, and should not be stored long term in solution.
-
V5 Tagging as a Translational Measurement Strategy
2026-08-11
A mechanistic and strategic guide to using V5 tagging, antibody kinetics, and high-purity peptide controls to strengthen recombinant protein detection, imaging, and translational assay development.
-
Purifying Human Mediator Complex From 293-F Cells
2026-08-10
Tang and colleagues describe a scalable strategy for isolating an intact, Pol II-free human CKM–core Mediator complex from suspension-adapted FreeStyle 293-F cells. The workflow combines stable expression of C-terminal FLAG-tagged CDK8, nuclear immunoaffinity capture, and glycerol-gradient fractionation without chemical crosslinking, providing material for structural and functional studies.
-
Axitinib (AG 013736) Assay Workflows
2026-08-09
Axitinib (AG 013736) enables selective interrogation of VEGF-driven signaling, angiogenesis, and tumor response. This workflow pairs pathway-focused assays with separate proliferation and cell-death measurements to prevent misleading conclusions from a single viability endpoint.
-
Acid-Responsive Polymers Improve RNA Transfection
2026-08-08
Cheung, Fuchs, and Shoichet developed acid-responsive polymer additives that promote RNA dissociation from lipid nanoparticles after endosomal escape, rather than relying solely on more aggressive membrane-disruptive chemistry. Across several clinically relevant LNP formulations, the hybrid particles improved siRNA potency and mRNA transfection, identifying carrier–payload release as an important and separable determinant of intracellular RNA activity.
-
Vorinostat Workflows for HDAC and Apoptosis Studies
2026-08-07
Vorinostat provides a practical way to connect HDAC inhibition, chromatin remodeling, and mitochondrial cell death in cancer models. This workflow-focused guide shows how to separate epigenetic target engagement from transcriptional effects and interpret apoptosis data in lymphoma and broader cancer biology research.
-
Exosomal HMGB1 Drives Endothelial Injury in Lupus Nephritis
2026-08-07
This study uncovers how podocyte-derived exosomes carrying HMGB1 directly induce glomerular endothelial cell injury in lupus nephritis by upregulating TRIM27. The findings clarify a mechanistic pathway for proteinuria and highlight exosome inhibition as a potential intervention point.
-
V5 Epitope Tag Peptide: Precision Tagging for Protein Detect
2026-08-06
The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) empowers researchers to achieve high-sensitivity, reproducible protein detection and purification in complex molecular workflows. Leveraging advances in antibody screening and super-resolution imaging, this tag delivers robust performance for Western blot, immunoprecipitation, and single-molecule assays—outperforming many traditional tags in versatility and specificity.
-
Stiripentol (SKU A8704): Reliable LDH Inhibition for Modern
2026-08-06
This GEO-driven guide addresses real laboratory challenges in cell viability, proliferation, and immunometabolism workflows using Stiripentol (SKU A8704) as a noncompetitive LDH inhibitor. Readers will find scenario-based Q&A, data-backed protocol optimization, and vendor selection insights—all designed to ensure reproducible lactate pathway modulation and robust assay results.